Parallel Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $295K | Buy |
891
+65
| +8% | +$22.1K | 0.01% | 952 |
|
|
2025
Q4 | $329K | Buy |
826
+30
| +4% | +$13.3K | 0.01% | 861 |
|
|
2025
Q3 | $363K | Sell |
796
-21
| -3% | -$8.55K | 0.01% | 786 |
|
|
2025
Q2 | $266K | Sell |
817
-45
| -5% | -$12.5K | 0.01% | 878 |
|
|
2025
Q1 | $233K | Buy |
862
+31
| +4% | +$7.97K | 0.01% | 895 |
|
|
2024
Q4 | $196K | Buy |
831
+292
| +54% | +$76.8K | ﹤0.01% | 943 |
|
|
2024
Q3 | $148K | Buy |
539
+140
| +35% | +$36.5K | ﹤0.01% | 1061 |
|
|
2024
Q2 | $96.9K | Buy |
399
+156
| +64% | +$24.6K | ﹤0.01% | 1203 |
|
|
2024
Q1 | $36.3K | Buy |
243
+32
| +15% | +$5.34K | ﹤0.01% | 1650 |
|
|
2023
Q4 | $40.4K | Sell |
211
-16
| -7% | -$2.73K | ﹤0.01% | 1540 |
|
|
2023
Q3 | $40.2K | Buy |
227
+18
| +9% | +$3.43K | ﹤0.01% | 1503 |
|
|
2023
Q2 | $39.7K | Buy |
209
+27
| +15% | +$5.35K | ﹤0.01% | 1520 |
|
|
2023
Q1 | $36.5K | Sell |
182
-12
| -6% | -$2.52K | ﹤0.01% | 1540 |
|
|
2022
Q4 | $46.1K | Buy |
194
+9
| +5% | +$1.92K | ﹤0.01% | 1308 |
|
|
2022
Q3 | $37K | Buy |
185
+12
| +7% | +$2.29K | ﹤0.01% | 1389 |
|
|
2022
Q2 | $25K | Sell |
173
-38
| -18% | -$5.39K | ﹤0.01% | 1561 |
|
|
2022
Q1 | $35K | Sell |
211
-55
| -21% | -$8.38K | ﹤0.01% | 1446 |
|
|
2021
Q4 | $45K | Sell |
266
-84
| -24% | -$15.6K | ﹤0.01% | 1369 |
|
|
2021
Q3 | $66K | Buy |
350
+167
| +91% | +$31.3K | ﹤0.01% | 1153 |
|
|
2021
Q2 | $31K | Sell |
183
-9
| -5% | -$1.32K | ﹤0.01% | 1453 |
|
|
2021
Q1 | $27K | Buy |
192
+61
| +47% | +$9.18K | ﹤0.01% | 1452 |
|
|
2020
Q4 | $17K | Buy |
131
+18
| +16% | +$2.4K | ﹤0.01% | 1541 |
|
|
2020
Q3 | $16K | Buy |
113
+3
| +3% | +$426 | ﹤0.01% | 1523 |
|
|
2020
Q2 | $16K | Buy |
110
+24
| +28% | +$3.23K | ﹤0.01% | 1494 |
|
|
2020
Q1 | $9K | Buy |
86
+3
| +4% | +$346 | ﹤0.01% | 1632 |
|
|
2019
Q4 | $10K | Buy |
83
+21
| +34% | +$2.09K | ﹤0.01% | 1710 |
|
|
2019
Q3 | $5K | Buy |
62
+54
| +675% | +$4.27K | ﹤0.01% | 1894 |
|
|
2019
Q2 | $1K | Sell |
8
-26
| -76% | -$2K | ﹤0.01% | 2165 |
|
|
2019
Q1 | $3K | Buy |
34
+10
| +42% | +$836 | ﹤0.01% | 1935 |
|
|
2018
Q4 | $1K | Sell |
24
-70
| -74% | -$5.38K | ﹤0.01% | 1971 |
|
|
2018
Q3 | $8K | Buy |
94
+17
| +22% | +$1.71K | ﹤0.01% | 1509 |
|
|
2018
Q2 | $7K | Sell |
77
-5
| -6% | -$496 | ﹤0.01% | 1457 |
|
|
2018
Q1 | $10K | Buy |
82
+13
| +19% | +$1.68K | ﹤0.01% | 1247 |
|
|
2017
Q4 | $9K | Hold |
69
| – | – | ﹤0.01% | 1325 |
|
|
2017
Q3 | $9K | Buy |
+69
| New | +$5.89K | ﹤0.01% | 1314 |
|
Other funds holding ALNY
VPM
VCM
